Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fatimah AlHussain, Yazed AlRuthia, Hazem Al-Mandeel, Arwa Bellahwal, Fadia Alharbi, Yasser Almogbel, Oriana Awwad, Roua Dala'een & Fawaz Abdullah Alharbi. (2020) Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program. Patient Preference and Adherence 14, pages 737-746.
Read now
Read now
Mina Amiri, Ali Kabir, Fatemeh Nahidi, Maryam Shekofteh & Fahimeh Ramezani Tehrani. (2018) Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. The European Journal of Contraception & Reproductive Health Care 23:1, pages 64-77.
Read now
Read now
Jonette Keri & Michael Shiman. (2009) An update on the management of acne vulgaris. Clinical, Cosmetic and Investigational Dermatology 2, pages 105-110.
Read now
Read now
Articles from other publishers (36)
Leander Corrie, Ankit Awasthi, Jaskiran Kaur, Sukriti Vishwas, Monica Gulati, Indu Pal Kaur, Gaurav Gupta, Nagavendra Kommineni, Kamal Dua & Sachin Kumar Singh. (2023) Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals 16:2, pages 197.
Crossref
Crossref
Lali Pkhaladze, Vittorio Unfer & Didier Dewailly. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
151
165
.
Emily N. Hilz. (2022) Methods and considerations for the use of hormonal contraceptives in rat models of neurobehavior. Frontiers in Neuroendocrinology 66, pages 101011.
Crossref
Crossref
Ryan M. Svoboda, Nanjiba Nawaz & Andrea L. Zaenglein. (2022) Hormonal Treatment of Acne and Hidradenitis Suppurativa in Adolescent Patients. Dermatologic Clinics 40:2, pages 167-178.
Crossref
Crossref
Maria Rocha & Eduardo Rocha. (2022) Synthetic Progestins in Waste and Surface Waters: Concentrations, Impacts and Ecological Risk. Toxics 10:4, pages 163.
Crossref
Crossref
Sarah A. KanbourAdrian S. Dobs. (2022) Hyperandrogenism in Women with Polycystic Ovarian Syndrome: Pathophysiology and Controversies. Androgens: Clinical Research and Therapeutics 3:1, pages 22-30.
Crossref
Crossref
Konstantinos AnastassakisKonstantinos Anastassakis. 2022. Androgenetic Alopecia From A to Z. Androgenetic Alopecia From A to Z
187
192
.
Balachandran Kumarendran, Michael W. O'Reilly, Anuradhaa SubramanianDana ŠumiloKonstantinos ToulisKrishna M. GokhaleChandrika N. Wijeratne, Arri CoomarasamyAbd A. TahraniLaurent Azoulay, Wiebke ArltKrishnarajah Nirantharakumar. (2021) Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study. Diabetes Care 44:12, pages 2758-2766.
Crossref
Crossref
Yogamaya D Prabhu, Abilash Valsala Gopalakrishnan & Selvaraj Mohana Roopan. 2021. Phytopharmaceuticals. Phytopharmaceuticals
287
300
.
Franklin José Espitia De La Hoz. (2021) Indicaciones de la drospirenona más allá de la anticoncepción.. Revista Ciencias Biomédicas 10:2, pages 120-128.
Crossref
Crossref
Albe Carina Swanepoel, Janette Bester & Zelda de Lange-Loots. (2020) Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users. Microscopy and Microanalysis 26:5, pages 1007-1013.
Crossref
Crossref
Albe Carina SwanepoelJanette BesterOdette EmmersonPrashilla SomaDerylize BeukesMari van ReenenDu Toit LootsIlse du Preez. (2020) Serum Metabolome Changes in Relation to Prothrombotic State Induced by Combined Oral Contraceptives with Drospirenone and Ethinylestradiol. OMICS: A Journal of Integrative Biology 24:7, pages 404-414.
Crossref
Crossref
Mattison Craig, Heide S. Temples & Beth Weir. (2020) Polycystic Ovarian Syndrome in Adolescents: Early Diagnosis and Intervention. Journal of Pediatric Health Care 34:2, pages 166-170.
Crossref
Crossref
Shailaja Nair, Yolaine Nkamga & Bryson Hoover-Hankerson. 2020. Advanced Concepts in Human Immunology: Prospects for Disease Control. Advanced Concepts in Human Immunology: Prospects for Disease Control
371
386
.
Mariagrazia StracquadanioMariagrazia Stracquadanio. 2020. Managing Women’s Hyperandrogenism. Managing Women’s Hyperandrogenism
35
83
.
Hamid Reza Nejabati, Nasser Samadi, Leila Roshangar & Mohammad Nouri. (2019) N1-methylnicotinamide as a possible modulator of cardiovascular risk markers in polycystic ovary syndrome. Life Sciences 235, pages 116843.
Crossref
Crossref
Odette Emmerson, Janette Bester, Barend G. Lindeque & Albe C. Swanepoel. (2018) The Impact of Two Combined Oral Contraceptives Containing Ethinyl Estradiol and Drospirenone on Whole Blood Clot Viscoelasticity and the Biophysical and Biochemical Characteristics of Erythrocytes. Microscopy and Microanalysis 24:6, pages 713-728.
Crossref
Crossref
Mina Amiri, Fahimeh Ramezani Tehrani, Fatemeh Nahidi, Ali Kabir & Fereidoun Azizi. (2018) Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. JMIR Research Protocols 7:4, pages e113.
Crossref
Crossref
N Larivée, S Suissa, M Eberg, L Joseph, MJ Eisenberg, HA Abenhaim & KB Filion. (2017) Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. BJOG: An International Journal of Obstetrics & Gynaecology 124:11, pages 1672-1679.
Crossref
Crossref
Mina Amiri, Fatemeh Nahidi, Davood Khalili, Razieh Bidhendi-Yarandi & Fahimeh Ramezani Tehrani. (2017) Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol. JMIR Research Protocols 6:9, pages e191.
Crossref
Crossref
Renate Louw-du Toit, Karl-Heinz Storbeck, Meghan Cartwright, Angelique Cabral & Donita Africander. (2017) Progestins used in endocrine therapy and the implications for the biosynthesis and metabolism of endogenous steroid hormones. Molecular and Cellular Endocrinology 441, pages 31-45.
Crossref
Crossref
Joanna Smajdor, Robert Piech & Beata Paczosa-Bator. (2017) Voltammetric Determination of Drospirenone on Mercury Film Electrode. Journal of The Electrochemical Society 164:6, pages H311-H315.
Crossref
Crossref
Ricardo Azziz, Enrico Carmina, ZiJiang Chen, Andrea Dunaif, Joop S. E. Laven, Richard S. Legro, Daria Lizneva, Barbara Natterson-Horowtiz, Helena J. Teede & Bulent O. Yildiz. (2016) Polycystic ovary syndrome. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Albe C. Swanepoel, Amcois Visagie & Etheresia Pretorius. (2016) Synthetic Hormones and Clot Formation. Microscopy and Microanalysis 22:4, pages 878-886.
Crossref
Crossref
S. Morris, S. Grover & M. A. Sabin. (2016) What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? a review of current practice recommendations. Clinical Obesity 6:1, pages 1-18.
Crossref
Crossref
P. M. Spritzer & A. B. Motta. (2015) Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment. International Journal of Clinical Practice 69:11, pages 1236-1246.
Crossref
Crossref
Kavitha Tharian & Justin Warner. (2015) Polycystic ovarian syndrome in adolescent girls. Paediatrics and Child Health 25:7, pages 319-324.
Crossref
Crossref
Hong LEI & Li-cheng FENG. (2014) Study on effects of acupuncture on menstruation and endocrine in patients of normal body weight with polycystic ovary syndrome. World Journal of Acupuncture - Moxibustion 24:2, pages 10-14.
Crossref
Crossref
Beth McAvey & Harry Lieman. 2014. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
223
242
.
S.T. Bird, J.A.C. Delaney, M. Etminan, J.M. Brophy & A.G. Hartzema. (2013) Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?. Journal of Thrombosis and Haemostasis 11:6, pages 1059-1068.
Crossref
Crossref
Evanthia Diamanti-Kandarakis, Shahla Nader & Dimitrios PanidisGaetano LombardiVincenza Di StasiAlessio VolpeSilvia SavastanoAnnamaria ColaoFrancesco Orio. 2013. Novel Insights into the Pathophysiology & Treatment of PCOS. Novel Insights into the Pathophysiology & Treatment of PCOS
50
59
.
Lekha Saha, Sharonjeet Kaur & Pradip Kumar Saha. (2012) Pharmacotherapy of polycystic ovary syndrome - an update. Fundamental & Clinical Pharmacology 26:1, pages 54-62.
Crossref
Crossref
Kavitha Tharian & Justin Warner. (2011) Polycystic ovarian syndrome in adolescent girls. Paediatrics and Child Health 21:7, pages 309-314.
Crossref
Crossref
Anton Orlin, Stephen E Orlin, George A Makar & Vatinee Y Bunya. (2010) Presumed Corneal Copper Deposition and Oral Contraceptive Use. Cornea 29:4, pages 476-478.
Crossref
Crossref
Patricia Myriam Vuguin. (2010) Interventional studies for polycystic ovarian syndrome in children and adolescents. Pediatric Health 4:1, pages 59-73.
Crossref
Crossref
Gabriella Garruti, Raffaella Depalo, Maria Grazia Vita, Filomenamila Lorusso, Federica Giampetruzzi, Aurelia Bellomo Damato & Francesco Giorgino. (2009) Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment. Reproductive BioMedicine Online 19:4, pages 552-563.
Crossref
Crossref